MAAT PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of MAAT for the last semiannual is 1.72 M EUR, and it's 102.47% higher compared to the previous semiannual. The net income of H1 24 is -12.86 M EUR.